These changes are evidenced by alterations in the insulin–glucagon axis metabolites and modified incretin pathway markers, accompanied by significant changes in sphingolipid and phospholipid metabolism during pancreatitis [69,70]. The gene discussed is GCG; the disease is pancreatitis.